New drug offers hope to keep bladder in cancer patients unsuitable for surgery
NCT ID NCT03697850
Summary
This study is testing a drug called atezolizumab to see if it can help control muscle-invasive bladder cancer and prevent it from coming back after standard chemotherapy and radiation. It is for patients who are not eligible for or refuse major surgery to remove their bladder. The main goal is to see if this treatment approach can successfully keep the bladder cancer-free and avoid the need for bladder removal.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Antoine Lacassagne
Nice, France
-
Centre Azureen de Cancerologie
Mougins, 06250, France
-
Centre Georges Francois Leclerc
Dijon, France
-
Centre Jean Perrin
Clermont-Ferrand, France
-
Centre Oscar Lambret
Lille, France
-
Chu Lyon Sud
Pierre-Bénite, France
-
Gustave Roussy
Villejuif, 94800, France
-
Hopital Saint Louis
Paris, France
-
Hôpital Pitie Salpetriere
Paris, France
-
INSTITUT de CANCEROLOGIE DE L'OUEST - site René Gauducheau
Saint-Herblain, France
-
Icm Val D'Aurelle
Montpellier, France
-
Institut Bergonie
Bordeaux, France
Conditions
Explore the condition pages connected to this study.